Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
7/31/2020
CDE Solicits Comments on Four Draft Technical Guidelines
7/31/2020
Harbour BioMed Enters Strategic Partnership with Viva Biotech on Incub...
7/31/2020
Gan & Lee Pharmaceuticals Initiates First-in Human Phase 1 Clinica...
7/31/2020
NMPA Suspends Import of Sanyo Chemical's Methoxyphenamine
7/30/2020
NHC Issues Notice to Step Up Single Disease Group Quality Control and ...
7/29/2020
Henlius and Accord Receive EMA Approval for Trastuzumab Biosimilar
7/29/2020
NHC Solicits Comments on the Rules for Clinical Application of Antitum...
7/28/2020
IQVIA: Overall Chinese Pharma Market Growth Rebounded to 8.4% in 2019
7/28/2020
Chi-Med's NDA for Savolitinib in Non-Small Cell Lung Cancer Granted Pr...
7/28/2020
Chi-Med and Lilly Amend/Expand Agreement to Co-promote Elunate in Chin...
7/25/2020
BeiGene Announces Acceptance of NDA for Pamiparib in Ovarian Cancer in...
7/25/2020
Recent Executive Moves
7/24/2020
CDE Solicits Comments on the Draft Technical Guidelines for Pharmacy S...
7/24/2020
CDE Issues the Guidelines for Non-inferiority Design of Drug Clinical ...
7/24/2020
Chi-Med Initiates a Phase I Trial of IDH1/2 Dual Inhibitor for Hematol...
7/24/2020
Tigermed to Raise At Least $1B in Hong Kong IPO
7/23/2020
State Council Issues Notice on Core Tasks to Deepen Healthcare Reform ...
7/23/2020
Hansoh and EQRx Enter Strategic Deal for Almonertinib
7/23/2020
NHC Issues Notice to Boost Surveillance of Pediatric Antibiotic Clinic...
7/23/2020
NHC Issues Official Notice for Sustained Clinical Application Regulati...
7/22/2020
SinoMab Entered into Strategic Deal with D2M for Novel Drug Target Ide...
7/22/2020
143 Listed Chinese MedPharm Cos Report H1 Performance
7/22/2020
JW Therapeutics Buys Hong Kong Anti-cancer Drug Maker Syracuse Biophar...
7/20/2020
BeiGene and Assembly Bio Ink $540M China HBV Deal
7/20/2020
CDE Issues the Clinical Research Guidelines for Rituximab Biosimilar
7/20/2020
CDE Issues the Clinical Research Guidelines for Trastuzumab Biosimilar...
7/20/2020
CDE Issues the Guideline on the Submission of Clinical Trial Data
7/20/2020
NHC and SATCM Issues Provisions for Administration of Medical Consorti...
7/19/2020
Recent Executive Moves
7/17/2020
IQVIA: Shanghai Drug Market Growth Up Substantially in 2019
Page:
111
/
357
Total number of articles:
10684
:
[First]
[<<]
[109]
[110]
[111]
[112]
[113]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit